Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
J Luo, D Yan, S Li, S Liu, F Zeng… - Journal of cellular …, 2020 - Wiley Online Library
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
[HTML][HTML] Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
J Luo, D Yan, S Li, S Liu, F Zeng… - Journal of Cellular …, 2020 - ncbi.nlm.nih.gov
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
J Luo, D Yan, S Li, S Liu, F Zeng… - Journal of Cellular …, 2020 - search.proquest.com
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
J Luo, D Yan, S Li, S Liu, F Zeng… - Journal of cellular …, 2020 - pubmed.ncbi.nlm.nih.gov
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
Allopurinol Reduces Oxidative Stress and Activates Nrf2/p62 to Attenuate Diabetic Cardiomyopathy in Rats
J Luo, D YAN, S Li, SM Liu, F Zeng… - Journal of Cellular and …, 2020 - hub.hku.hk
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
[PDF][PDF] Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
J Luo, D Yan, S Li, S Liu, F Zeng, CW Cheung, H Liu… - 2019 - academia.edu
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
[PDF][PDF] Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
J Luo, D Yan, S Li, S Liu, F Zeng, CW Cheung, H Liu… - 2019 - researchgate.net
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
[引用][C] Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
J Luo, D Yan, S Li, S Liu, F Zeng, CW Cheung… - Journal of Cellular and …, 2019 - cir.nii.ac.jp
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic
cardiomyopathy in rats | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
cardiomyopathy in rats | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
J Luo, D Yan, S Li, S Liu, F Zeng… - Journal of Cellular …, 2019 - europepmc.org
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) …
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
J Luo, D Yan, S Li, S Liu, F Zeng… - Journal of cellular …, 2020 - escholarship.org
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …
mechanism is unclear. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) following …